Premier Alternatives

Neuro42

San Francisco, CA · Founded 2020 · Privately Held (backing)

Developer of portable magnetic resonance imaging machines designed to offer diagnosis and interventions for neurological conditions. Neuro42 is based in San Francisco, CA and was founded in 2020. Its last known valuation is $135 million. It has raised $30 million across 2 recorded rounds; the latest was a $15.6 million early-stage round in Sep 2024.

Last price · $/share
—
Implied valuation
$135.0M
Total raised
$30.0M
Last round
Early Stage VC
Sep 2024

Neuro42 key facts

  • Developer of portable magnetic resonance imaging machines designed to offer diagnosis and interventions for neurological conditions.
  • Neuro42’s last known valuation is $135.0M.
  • It has raised $30.0M across 2 recorded rounds; the latest was Early Stage VC ($15.6M) in Sep 2024.
  • Notable investors include Keiretsu Forum, ShangBay Capital, Blacktop Capital, Frederic Moll, K2X — 12 tracked in total.
  • Neuro42 has filed 2 Form Ds with the SEC, most recently Sep 2024 ($15.6M sold to 85 investors).
  • Status: Privately Held (backing).
Free account
More of Neuro42 with a free account
  • ·The complete investor list: 12 names
  • ·Watch Neuro42: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Neuro42 funding rounds

2 rounds
Sep 2024Early Stage VC$15.6MSEC filing▮
May 2024Early Stage VC$6.7MSEC filing▮
Full funding history →

Neuro42 valuation

Neuro42's last known valuation is $135 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Neuro42 raised?

Neuro42 has raised $30 million in total; 2 of its rounds are on record. The largest on record was a $6.7 million early-stage round in May 2024; the most recent was a $15.6 million early-stage round in Sep 2024.

Neuro42 has filed 2 Form Ds with the SEC, most recently in Sep 2024 ($15.6 million sold to 85 investors).

Neuro42 investors

12 investors are on record for Neuro42, including Keiretsu Forum, ShangBay Capital, Blacktop Capital and Frederic Moll. The early-stage round in Sep 2024 drew 85 investors.

About Neuro42

Developer of portable magnetic resonance imaging machines designed to offer diagnosis and interventions for neurological conditions. The company's device focuses on imaging for triaging, screening, diagnosing, and intervening in the treatment of various brain conditions that range from traumatic injury to epilepsy and tumors, enabling patients with a point-of-care shift for those who have experienced a stroke and facilitating the use of direct robotic interventions outside of the traditional magnetic resonance suite.

Sector
Healthcare
HQ
San Francisco, CA, United States
Founded
2020
Employees
31
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$135.0M

Neuro42’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.